Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 67 Records) |
| Query Trace: Schizophrenia and DRD4[original query] |
|---|
| Association of DRD4 uVNTR and TP53 codon 72 polymorphisms with schizophrenia: a case-control study. BMC medical genetics 2009 Dec 10 (1): 1. Lung For-Wey, Shu Bih-Ching, Kao Wei-Tsung, Chen C Nathan, Ku Yu-Chi, Tzeng Dong-She |
| Association study of polymorphisms in the promoter region of DRD4 with schizophrenia, depression, and heroin addiction. Brain research 2010 Nov 1359 227-32. Lai J H, Zhu Y S, Huo Z H, Sun R F, Yu B, Wang Y P, Chai Z Q, Li S |
| [Family based association study of DRD1, DRD2, DRD3, DRD4, DAT, COMT gene polymorphism in schizophrenia]. Psychiatria polska 0 44 (3): 405-13. Pawe? Kapelski, Hauser Joanna, Skibi?ska Maria, Szczepankiewicz Aleksandra, Dmitrzak-Weglarz Monika, Gorzkowska Karolina, Pawlak Joanna, Czerski Piotr |
| Habituation in prepulse inhibition is affected by a polymorphism on the NMDA receptor 2B subunit gene (GRIN2B). Psychiatric genetics 2010 Oct 20 (5): 191-8. Hokyo Akira, Kanazawa Tetsufumi, Uenishi Hiroyuki, Tsutsumi Atsushi, Kawashige Seiya, Kikuyama Hiroki, Glatt Stephen J, Koh Jun, Nishimoto Yoshiyuki, Matsumura Hitoshi, Motomura Naoyasu, Yoneda Hiros |
| Associations between DRDs and schizophrenia in a Korean population: multi-stage association analyses. Experimental & molecular medicine 2011 Jan 43 (1): 44-52. Lee Kyu Young, Joo Eun-Jeong, Ji Yong Ick, Kim Duk-Hwan, Park Joo Bae, Chung In-Won, Lee Sang Ick, Joo Yeon Ho, Ahn Yong Min, Song Joo Yun, Kim Yong S |
| Genetic polymorphisms in dopamine- and serotonin-related genes and treatment responses to risperidone and perospirone. Psychiatry investigation 2009 Sep 6 (3): 3. Tsutsumi Atsushi, Kanazawa Tetsufumi, Kikuyama Hiroki, Okugawa Gaku, Uenishi Hiroyuki, Miyamoto Toshio, Matsumoto Naoki, Koh Jun, Shinosaki Kazuhiro, Kishimoto Toshifumi, Yoneda Hiroshi, Kinoshita Toshihi |
| Comparative study on gene tags of the neurotransmission system in schizophrenic and suicidal subjects. Collegium antropologicum 2010 Dec 34 (4): 1427-32. Molnar Sven, Mihanovi? Mate, Grah Majda, Kezi? Slobodanka, Filakovi? Pavo, Degmeci? Dun |
| The genetic validation of heterogeneity in schizophrenia. Behavioral and brain functions : BBF 2011 7 (1): 43. Tsutsumi Atsushi, Glatt Stephen J, Kanazawa Tetsufumi, Kawashige Seiya, Uenishi Hiroyuki, Hokyo Akira, Kaneko Takao, Moritani Makiko, Kikuyama Hiroki, Koh Jun, Matsumura Hitoshi, Yoneda Hiros |
| The interleukin 10 promoter haplotype ACA and the long-form variant of the DRD4 uVNTR polymorphism are associated with vulnerability to schizophrenia. Psychiatry research 2011 Jul 188 (2): 294-6. Lung For-Wey, Yang Ming-Chang, Shu Bih-Chi |
| DRD4 VNTR polymorphism and age at onset of severe mental illnesses. Neuroscience letters 2012 Jun 519 (1): 9-13. Gonçalves Vanessa Faria, Tiwari Arun K, de Luca Vincenzo, Kong Say Li, Zai Clement, Tampakeras Maria, Mackenzie Bronwyn, Sun Lei, Kennedy James |
| Antipsychotic-induced movement disorders in long-stay psychiatric patients and 45 tag SNPs in 7 candidate genes: a prospective study. PloS one 2012 7 (12): e50970. Bakker P Roberto, Al Hadithy Asmar F Y, Amin Najaf, van Duijn Cornelia M, van Os Jim, van Harten Peter |
| Genetic association between the DRD4 promoter polymorphism and clozapine-induced sialorrhea. Psychiatric genetics 2014 Dec 24 (6): 273-6. Rajagopal Veeramanikandan, Sundaresan Lakshmikirupa, Rajkumar Anto P, Chittybabu Chithra, Kuruvilla Anju, Srivastava Alok, Balasubramanian Poonkuzhali, Jacob Kuruthukulangara S, Jacob Mol |
| [Brain neurotransmitter systems gene Polymorphism: the Search for pharmacogenetic markers of efficacy of haloperidol in Russians and Tatars]. Molekuliarnaia biologiia 0 49 (6): 959-67. Gareeva A E, Kinyasheva K O, Galaktionova D Yu, Sabirov E T, Valinourov R G, Chudinov A V, Zasedatelev A S, Nasedkina T V, Khusnutdinova And E |
| Polymorphisms of dopamine receptor genes and risk of visual hallucinations in Parkinson's patients. European journal of clinical pharmacology 2016 Aug . Ferrari M, Comi C, Marino F, Magistrelli L, De Marchi F, Cantello R, Riboldazzi G, Bono G, Cosentino |
| Associations between a locus downstream DRD1 gene and cerebrospinal fluid dopamine metabolite concentrations in psychosis. Neuroscience letters 2016 Mar . Andreou Dimitrios, Söderman Erik, Axelsson Tomas, Sedvall Göran C, Terenius Lars, Agartz Ingrid, Jönsson Erik |
| Preliminary evidence that negative symptom severity relates to multilocus genetic profile for dopamine signaling capacity and D2 receptor binding in healthy controls and in schizophrenia. Journal of psychiatric research 2016 Nov 86 9-17. Eisenstein Sarah A, Bogdan Ryan, Chen Ling, Moerlein Stephen M, Black Kevin J, Perlmutter Joel S, Hershey Tamara, Barch Deanna |
| Uncovering obsessive-compulsive disorder risk genes in a pediatric cohort by high-resolution analysis of copy number variation. Journal of neurodevelopmental disorders 2016 8 36. Gazzellone Matthew J, Zarrei Mehdi, Burton Christie L, Walker Susan, Uddin Mohammed, Shaheen S M, Coste Julie, Rajendram Rageen, Schachter Reva J, Colasanto Marlena, Hanna Gregory L, Rosenberg David R, Soreni Noam, Fitzgerald Kate D, Marshall Christian R, Buchanan Janet A, Merico Daniele, Arnold Paul D, Scherer Stephen |
| cAMP levels in lymphocytes and CD4 regulatory T-cell functions are affected by dopamine receptor gene polymorphisms. Immunology 2017 Sep . Cosentino Marco, Kustrimovic Natasa, Ferrari Marco, Rasini Emanuela, Marino Fran |
| [A role of interactions between N-methyl-D-aspartate and dopamine receptors in facial emotion recognition impairment in schizophrenia]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 2017 117 (6): 47-52. Alfimova M V, Golimbet V E, Korovaitseva G I, Lezheiko T V, Tikhonov D V, Ganisheva T K, Berezin N B, Snegireva A A, Shemiakina T |
| Gene-gene interaction between DRD4 and COMT modulates clinical response to clozapine in treatment-resistant schizophrenia. Pharmacogenetics and genomics 2017 Oct . Rajagopal Veera M, Rajkumar Anto P, Jacob Kuruthukulangara S, Jacob Mol |
| A meta-analysis of data associating DRD4 gene polymorphisms with schizophrenia. Neuropsychiatric disease and treatment 2018 14 153-164. Xu Feng-Ling, Wu Xue, Zhang Jing-Jing, Wang Bao-Jie, Yao J |
| A pharmacogenetic study of patients with schizophrenia from West Siberia gets insight into dopaminergic mechanisms of antipsychotic-induced hyperprolactinemia. BMC medical genetics 2019 Apr 20 (Suppl 1): 47. Osmanova Diana Z, Freidin Maxim B, Fedorenko Olga Yu, Pozhidaev Ivan V, Boiko Anastasiia S, Vyalova Natalia M, Tiguntsev Vladimir V, Kornetova Elena G, Loonen Anton J M, Semke Arkadiy V, Wilffert Bob, Bokhan Nikolay A, Ivanova Svetlana |
| Interaction between lead and noradrenergic genotypes affects neurocognitive functions in attention-deficit/hyperactivity disorder: a case control study. BMC psychiatry 2020 Aug 20 (1): 407. Choi Jae-Won, Jung A-Hyun, Nam Sojeong, Kim Kyoung Min, Kim Jun Won, Kim Soo Yeon, Kim Bung-Nyun, Kim Jae-W |
| Genetic Variants Allegedly Linked to Antisocial Behaviour Are Equally Distributed Across Different Populations. Journal of personalized medicine 2021 Mar 11 (3): . Zampatti Stefania, Ragazzo Michele, Fabrizio Carlo, Termine Andrea, Campoli Giulia, Caputo Valerio, Strafella Claudia, Cascella Raffaella, Caltagirone Carlo, Giardina Emilia |
| The presence of polymorphisms in genes controlling neurotransmitter metabolism and disease prognosis in patients with prostate cancer: a possible link with schizophrenia. Oncotarget 2021 Mar 12 (7): 698-707. Zharinov Gennady M, Khalchitsky Sergei E, Loktionov Alexandre, Sogoyan Marina V, Khutoryanskaya Yulia V, Neklasova Natalia Yu, Bogomolov Oleg A, Smirnov Ilya V, Samoilovich Marina P, Skakun Vladimir N, Vissarionov Sergei V, Anisimov Vladimir |
| The Role of Dopaminergic Genes in Probabilistic Reinforcement Learning in Schizophrenia Spectrum Disorders. Brain sciences 2021 Dec 12 (1): . Frydecka Dorota, Misiak B?a?ej, Piotrowski Patryk, Bielawski Tomasz, Pawlak Edyta, K?osi?ska Ewa, Krefft Maja, Al Noaimy Kamila, Rymaszewska Joanna, Moustafa Ahmed A, Drapa?a Jaros? |
| Association of 11 variants of the dopaminergic and cognitive pathways genes with major depression, schizophrenia and bipolar disorder in the Pakistani population. The International journal of neuroscience 2023 8 1-26. Aisha Nasir Hashmi, Merlyn Sabin Raja, Rizwan Taj, Raees Ahmed Dharejo, Zehra Agha, Raheel Qamar, Maleeha Az |
| DRD4 VNTR 4/4 homozygosity as a genetic biomarker for treatment selection in patients with schizophrenia. Asian journal of psychiatry 2023 11 91 103831. Hao-Ming Yang, Hsuan Lung, Ming-Chang Yang, For-Wey Lu |
| Association of DRD2, DRD4 and COMT genes variants and their gene-gene interactions with antipsychotic treatment response in patients with schizophrenia. BMC psychiatry 2023 10 23 (1): 781. Narges Taheri, Rokhshid Pirboveiri, Mehdi Sayyah, Mahdi Bijanzadeh, Pegah Ghand |
| Family-based genome-wide association analysis of novelty seeking in a Korean schizophrenic population: A pilot study. Medicine 2024 6 103 (26): e38694. Ji Hye Kim, Byung Dae Lee, Je Min Park, Young Min Lee, Eunsoo Moon, Hwagyu Suh, Kyungwon Kim, Yoo Jun Kim, Hyun Ji Lee, Ha Young |
- Page last reviewed:Feb 1, 2024
- Content source: